{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T23:45:12Z","timestamp":1774482312554,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.transproceed.2023.03.011","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T07:25:49Z","timestamp":1682580349000},"page":"893-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of Short-Term and Long-Term Outcomes of Living Donor Liver Transplantation for Patients with a High Model for End-Stage Liver Disease Score"],"prefix":"10.1016","volume":"55","author":[{"given":"Daijiro","family":"Matoba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8828-1067","authenticated-orcid":false,"given":"Shogo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Iwagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisaku","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Tomimaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2023.03.011_bib0001","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0002","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/lt.20169","article-title":"Pretransplant MELD score and post liver transplantation survival in the UK and Ireland","volume":"10","author":"Jacob","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0003","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1034\/j.1600-6143.2003.00092.x","article-title":"Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C","volume":"3","author":"Onaca","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0004","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.transproceed.2006.02.091","article-title":"Risk factors for graft dysfunction after adult-to-adult living donor liver transplantation","volume":"38","author":"Marubashi","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00535-008-2168-7","article-title":"Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation","volume":"43","author":"Ishigami","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0006","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis C","volume":"140","author":"Stephanos","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0007","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2016.05.010","article-title":"Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: a European study","volume":"65","author":"Belli","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0008","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1499-3872(13)60042-9","article-title":"Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores","volume":"12","author":"Chok","year":"2013","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0009","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1016\/j.transproceed.2010.07.100","article-title":"Does model for end-stage liver disease score predict the short-term outcome of living donor liver transplantation?","volume":"42","author":"Li","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0010","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.transproceed.2008.03.016","article-title":"Analysis of liver transplantation outcome in patients with MELD Score >or\u00a0=\u00a030","volume":"40","author":"Ferraz-Neto","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0011","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0012","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0013","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.transproceed.2007.02.070","article-title":"Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure","volume":"39","author":"Wang","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0014","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/jlts.2003.50122","article-title":"Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients","volume":"9","author":"Hayashi","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00595-013-0523-7","article-title":"A high MELD score, combined with the presence of hepatitis C, is associated with a poor prognosis in living donor liver transplantation","volume":"44","author":"Ikegami","year":"2014","journal-title":"Surg Today"},{"issue":"8","key":"10.1016\/j.transproceed.2023.03.011_bib0016","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13006","article-title":"High MELD score does not adversely affect outcome of living donor liver transplantation: experience in 1000 recipients","volume":"31","author":"Yadav","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0017","doi-asserted-by":"crossref","first-page":"e14656","DOI":"10.1111\/ctr.14656","article-title":"Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis influence suitability for and outcome after living donor liver transplantation? A systematic review of the literature and expert panel recommendations","volume":"36","author":"Roll","year":"2022","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0018","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.transproceed.2012.02.006","article-title":"A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation","volume":"44","author":"Poon","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0019","first-page":"454","article-title":"Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation","volume":"29","author":"Hori","year":"2016","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0020","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon Alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C","volume":"339","author":"McHutchison","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0021","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","article-title":"Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus","volume":"352","author":"Poynard","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0022","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jhep.2005.05.019","article-title":"HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b\/ribavirin","volume":"43","author":"Moreno","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0023","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/lt.20883","article-title":"Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation","volume":"12","author":"Fernandez","year":"2006","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.transproceed.2023.03.011_bib0024","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13109","article-title":"Asunaprevir and daclatasvir for recurrent hepatitis C after liver transplantation: a Japanese multicenter experience","volume":"31","author":"Ikegami","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0025","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/ajt.12221","article-title":"Impact of sarcopenia on survival in patients undergoing living donor liver transplantation","volume":"13","author":"Kaido","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2023.03.011_bib0026","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/lt.26447","article-title":"Associations of sarcopenia with graft failure and mortality in patients undergoing living donor liver transplantation","volume":"28","author":"Sim","year":"2022","journal-title":"Liver Transpl"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134523001495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134523001495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:45:06Z","timestamp":1758577506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134523001495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0041134523001495"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.03.011","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of Short-Term and Long-Term Outcomes of Living Donor Liver Transplantation for Patients with a High Model for End-Stage Liver Disease Score","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}